AI assistant
Sending…
aTYR PHARMA INC — Director's Dealing 2015
May 8, 2015
34337_dirs_2015-05-08_26d2944d-b713-4d07-a6ab-d69a56bebb15.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: aTYR PHARMA INC (LIFE)
CIK: 0001339970
Period of Report: 2015-05-06
Reporting Person: Chrzanowski Holly D. (See Remarks)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-06 | Stock Option (right to buy) | $14.00 | A | 11943 | Acquired | 2025-05-06 | Common Stock (11943) | Direct |
Footnotes
F1: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on May 6, 2015, such that this option is fully exercisable on May 6, 2019. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
F2: Not applicable.
More from aTYR PHARMA INC
Delisting Announcement
2026
Jun 8
Report Publication Announcement
2026
Jun 1
Interim / Quarterly Report
2026
May 15
Earnings Release
2026
May 15
Regulatory Filings
2026
May 11
Remuneration Information
2026
Mar 26
Major Shareholding Notification
2026
Mar 26
Call Transcript
2026
Mar 11
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4